AP
APYI.US Aspyra Inc
- Market cap
- USD 34.00
- P/E
- -
- P/B
- 0.01x
- ROE
- -144.9%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2009.
Is APYI.US undervalued?
Graham numberThe Graham number of Aspyra Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Aspyra Inc fundamental analysis
No fundamental analysis for Aspyra Inc yet.
Aspyra Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Aspyra Inc
Aspyra Inc. provides health care products and services for the laboratory and imaging marketplaces. The company provides PACS imaging solutions, and laboratory information system (LIS). It offers engineered workflow solutions that include software, interfaces, hardware, and professional services to various markets comprising specialty labs, reference labs, clinics, hospitals, imaging centers, and orthopedic practices. The company was formerly known as Creative Computer Appli…
Full company profileAspyra Inc financial statements
2009 annualized: Fiscal year 2009 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2009, the balance sheet is the latest quarter. Figures change when the annual report is published.
Aspyra Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 8.90M | 7.22M | 5.95M | 7.83M | 7.38M | 2.39M | 7.21M | 12.7M | 10.3M | 8.53M | 7.84M |
| Gross Profit | 4.90M | 3.66M | 2.64M | 4.24M | 3.81M | 1.24M | 3.51M | 5.88M | 4.87M | 3.92M | 3.38M |
| Operating Income | 800K | 635K | 524K | 724K | 129K | 267K | 1.68M | 3.34M | 4.20M | 4.70M | 4.38M |
| EBITDA | 1.40M | 73.5K | 213K | 1.48M | 748K | -88.0K | -1.10M | -1.96M | -2.61M | -2.85M | -2.78M |
| Net Income | 700K | -619K | -513K | 432K | 94.1K | -264K | -2.50M | -3.57M | -4.22M | -5.19M | -6.08M |
| EPS | 22 | -20 | -16 | 13 | 2.69 | -8.04 | -63 | -36 | -38 | -42 | -38 |
| Balance Sheet | |||||||||||
| Total Assets | 7.70M | 5.92M | 5.67M | 6.29M | 6.28M | 6.59M | 18.6M | 19.3M | 16.8M | 15.2M | 14.6M |
| Total Liabilities | 3.30M | 2.02M | 2.24M | 2.43M | 2.28M | 2.68M | 6.44M | 6.50M | 6.26M | 8.37M | 10.4M |
| Shareholders' Equity | 4.40M | 3.89M | 3.43M | 3.86M | 4.01M | 3.91M | 12.2M | 12.8M | 10.5M | 6.79M | 4.20M |
| Cash & Short-term Investments | 700K | 618K | 485K | 1.03M | 1.08M | 1.66M | 1.33M | 1.01M | 803K | -348K | 565K |
| Total Debt | 200K | 140K | 300K | 23.1K | 361.00 | 300K | 1.22M | 2.07M | 1.70M | 3.60M | 4.60M |
| Cash Flow | |||||||||||
| Operating Cash Flow | 1.10M | 610K | 420K | 1.13M | 604K | 160K | -638K | -2.23M | -1.62M | -1.69M | -2.15M |
| Capital Expenditure | 200K | 232K | 114K | 80.7K | 120K | 204K | 326K | 1.22M | 921K | 554K | 467K |
| Free Cash Flow | 900K | 379K | 306K | 1.05M | 483K | -44.1K | -964K | -3.45M | -2.54M | -2.24M | -2.62M |
| Ratios | |||||||||||
| ROE | 15.9% | -15.9% | -14.9% | 11.2% | 2.3% | -6.8% | -20.5% | -27.9% | -40.1% | -76.4% | -144.9% |
| ROA | 9.1% | -10.5% | -9.0% | 6.9% | 1.5% | -4.0% | -13.4% | -18.5% | -25.1% | -34.2% | -41.6% |
| Net Profit Margin | 7.9% | -8.6% | -8.6% | 5.5% | 1.3% | -11.0% | -34.7% | -28.1% | -41.1% | -60.9% | -77.6% |
| Debt to Equity | 0.05x | 0.04x | 0.09x | 0.01x | 0.00x | 0.08x | 0.10x | 0.16x | 0.16x | 0.53x | 1.10x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Aspyra Inc dividends
Aspyra Inc has not paid dividends in the last 9 fiscal years.
Last stock split: 1:101 on Apr 27, 2010.
Who owns Aspyra Inc
Ownership data of Aspyra Inc is not available yet.
Aspyra Inc company profile
- Company name
- Aspyra Inc
- Ticker
- APYI.US
- Exchange
- USA Stocks
- Listed since
- Jan 1, 1987
- Sector
- Healthcare
- Industry
- Health Care Technology
- Employees
- 69
- Fiscal year end
- December
- Address
- 7400 Baymeadows Way, Jacksonville, FL, United States, 32256
- Phone
- 888 731 0731
- Website
- aspyra.com
About Aspyra Inc
Aspyra Inc. provides health care products and services for the laboratory and imaging marketplaces. The company provides PACS imaging solutions, and laboratory information system (LIS). It offers engineered workflow solutions that include software, interfaces, hardware, and professional services to various markets comprising specialty labs, reference labs, clinics, hospitals, imaging centers, and orthopedic practices. The company was formerly known as Creative Computer Applications Inc. and changed its name to Aspyra Inc. in November 2005. Aspyra Inc. is based in Jacksonville, Florida.
Aspyra Inc management
2- Mr. Gary W. BennettPresident
- Mr. Danny ChinVice President of Operations